Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
-
Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum
-
FuelCell Energy Reports First Quarter of Fiscal 2025 Results
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings Inc
-
Man Group PLC : Form 8.3 - Serica Energy plc
-
Man Group PLC : Form 8.3 - Dalata Hotel Group
-
TORRAS Powers Ahead in 2025: Building a Robust Low-Temperature Charging Ecosystem
-
Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting
-
The Joint Corp. Names SVP Development
-
Microchip Technology Unveils 32-bit MCU Family with Integrated High-Performance Analog Peripherals
-
Paw-litics Heats Up on the Hill: Cutest Pets on Parliament Hill Contest Returns
-
XRP Investors Flock to BlocScale as $BLOC Token Surpasses 15% Sales Milestone – Is This XRP’s Next Big Thing?
-
First Watch Restaurant Group, Inc. Reports 2024 Financial Results and Provides Outlook for 2025
-
Second Trader in Axi’s Capital Allocation Program, Axi Select, Secures $1,000,000 in Funding
-
Eloro Resources Further Expands Major Silver Zone Intersecting 151.47 g Ag/t over 135m within a broader interval of 309m grading 90.92 g Ag/t in the Latest Definition Drilling at its Iska Iska Deposit
-
Aya Gold & Silver Announces February 2025 Production Results
-
Daxtra and PitchMe Partner to Improve Search and Match Capabilities through Enriched Candidate Profiles
-
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
Angus Gold Doubles the Strike Length of New High-Grade Gold Zone at Dorset West, Intersects 15.6 g/t Au over 3.5 metres in 100m-step out hole, Golden Sky Project, Wawa
-
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
-
Make Safety Your Lucky Charm This St. Patrick’s Day – Don’t Drive Impaired
-
Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025
-
BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
-
SalaryIQ Goes Global, Delivering Real-Time Competitive Intelligence in More than 30 Countries
-
CareCloud Requests Delisting of Series A Preferred Stock after Mandatory Conversion
-
Orange and Telesat sign multi-year partnership for Telesat Lightspeed LEO satellite connectivity and terrestrial infrastructure
-
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
-
Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
-
atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression
-
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call
-
Newton Golf Company Announces Name Change and 1-for-30 Reverse Stock Split
-
Space Norway selects Telesat Lightspeed Low Earth Orbit (LEO) connectivity solution
-
Brookfield Closes Infrastructure Structured Solutions Fund
-
Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market
-
PyroGenesis and GE Vernova Sign Memorandum of Understanding (MOU)
-
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
-
PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
-
Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum
-
Axonius Announces Adapt Conference and Adapt In Action Roadshow
-
Huhtamaki has met the sustainability targets for its EUR 500 million sustainability-linked bond issued in 2022
-
Kojamo announces final results of tender offer for its outstanding notes due 2026
-
Invitation to the Annual General Meeting
-
ECARX Announces Fourth Quarter and Full Year 2024 Unaudited Financial Results
-
Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiority
-
Gauzy Ltd. Announces Record Fourth Quarter and Full Year 2024 Results
-
Second Trader in Axi’s Capital Allocation Program, Axi Select, Secures $1,000,000 in Funding
-
KANZHUN LIMITED Announces Fourth Quarter and Full Year 2024 Financial Results
-
Endeavour Silver Announces Q4 2024 Financial Results; Earnings Call at 10AM PDT (1PM EDT) Today
-
Knight Therapeutics to Acquire Paladin

